• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about AWKNF

Recent news which mentions AWKNF

< Previous 1 2 3 Next >
World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them
August 30, 2022
Tickers ATAI AWKNF CYBN ENTBF
Tags NMDBF MNMD News
From Benzinga
There Could Be More Hope For Alcohol Addicts As This Company Enters U.S. Addiction Treatment And Relapse Prevention Market
August 19, 2022
Tickers ABT AWKNF HON RVLWF
Tags AWKNF Markets Awakn Life Sciences
From Benzinga
Awakn's Second Licensing Partnership Agreement In A Week, This Time In Canada: Ketamine For Pain Comorbidities
August 18, 2022
Tickers AWKNF
Tags Benzinga News Cannabis
From Benzinga
Awakn Enters U.S. Addiction Treatment & Relapse Prevention Market With Ketamine Therapy For Alcohol Use Disorder
August 16, 2022
Tickers AWKNF RVLWF
Tags Anthony Tennyson Psychedelics Markets
From Benzinga
Phase 3 Trial On Ketamine Therapy Gets Almost $2M From UK State Funding
July 20, 2022
Tickers AWKNF
Tags Market News Anthony Tennyson Psychedelics
From Benzinga
Awakn Life Sciences Receives Funding From UK Government To Identify Most Efficient Go-To-Market Pathway For Proprietary Ketamine-Assisted Therapy
July 18, 2022
Tickers ATAI AWKNF MNMD
Tags Benzinga Small Cap Partner Content
From Benzinga
Awakn Life Sciences: Business And Corporate Update For Psychedelics Biotech
July 15, 2022
Tickers AWKNF
Tags Markets AWKNF Licensing and Access Pathway application
From Benzinga
Michael Pollan's 'How To Change Your Mind' Now On Netflix, Here Are Reactions From Experts
July 14, 2022
Tickers AWKNF NFLX NUMIF
Tags Psychedelics Documentary Media Michael Pollan
From Benzinga
UK To Fund Development Of Awakn's Ketamine-Assisted Therapy Program For Alcohol Use Disorder In US And UK
July 05, 2022
Tickers AWKNF
Tags Financing Innovate UK Veristat
From Benzinga
Michael Pollan's 'How To Change Your Mind' Coming Soon To Netflix: Documentary Based On Psychedelics Best Seller
June 17, 2022
Tickers AWKNF MAPS NFLX NUMIF
Tags Benzinga News Global
From Benzinga
These 18 Clinical Trials Could Shape The Future Of The Psychedelics Industry
June 02, 2022
Tickers ATAI AWKNF BRAXF CMPS
Tags Psychedelics Yeji Jesse Lee SEEL
From Benzinga
Psyched: Medical Psychedelics In Davos, Canadian Sen Does Psychedelics, Ei.Ventures & Mycotopia To Merge Into $383M Company
May 24, 2022
Tickers AWKNF CMNDF CMPS IWINF
Tags CMNDF Psychedelics RVVTF
From Benzinga
Awakn Life Sciences Reports Completing World's First Ketamine Study For A Range Of Behavioral Addictions
May 24, 2022
Tickers AWKNF
Tags Awakn Life Sciences Biotech General
From Benzinga
Awakn's Study On Psychedelics For Treating Addiction Shows Promise, Will Undertake Broader Research
May 19, 2022
Tickers AWKNF
Tags News Awakn Life Sciences Cannabis
From Benzinga
Wake-Up Call: This Biotech Company Is Using Psychedelics To Treat Addiction
May 05, 2022
Tickers AWKNF CLXPF MNMD SF
Tags Benzinga Small Cap Partner Content
From Benzinga
Core One Labs Begins Trading On OTCQB
April 06, 2022
Tickers AWKNF CLABF NVMDF PSYCF
Tags Markets Penny Stocks Core One Labs
From Benzinga
Psyched: Atai, MindMed, Enveric and Mydecine Release 2021 Earnings, Bienstar Expands To Brazil & More!
April 06, 2022
Tickers ATAI AWKNF CYBN ENVB
Tags EPWCF Benzinga Small Cap
From Benzinga
Stifel Initiates Coverage On Awakn Life Sciences With A Speculative Buy, $8 Target Price Target
April 04, 2022
Tickers AWKNF
Tags Psychedelics Market News Analyst Ratings
From Benzinga
This Biotech Company Is Landing Ketamine-Assisted Therapy In England's Capital
March 31, 2022
Tickers ALKS ATAI AWKNF
Tags Small Cap Benzinga Partner Content
From Benzinga
Awakn Life Sciences Seeks To Treat Addictions: Gambling, Binge Eating And Compulsive Sexual Behavior
March 28, 2022
Tickers AWKNF
Tags AWKNF Penny Stocks Markets
From Benzinga
This Ketamine-Assisted Therapy Company Is Developing New Ways To Treat Alcohol Addiction
March 24, 2022
Tickers ALKS ATAI AWKNF KTTA
Tags General Biotech KTTA
From Benzinga
Mindset Pharma, Cybin Among Top Psychedelic Movers Of Today
February 08, 2022
Tickers ALID ATAI AWKNF CMPS
Tags Movers Market News FTRP
From Benzinga
Mind Medicine, Allied Among Top Psychedelic Movers Of Today
February 02, 2022
Tickers ALID ATAI AWKNF CMPS
Tags Markets AWKNF RVVTF
From Benzinga
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today
January 27, 2022
Tickers ALID ATAI AWKNF CMPS
Tags ATAI CYBN FTRP
From Benzinga
Psychedelic Stock Gainers And Losers From January 24, 2022
January 24, 2022
Tickers ALID ATAI AWKNF CMPS
Tags IGXT BZI/PSYCH CMPS
From Benzinga
Psychedelic Stock Gainers And Losers From January 21, 2022
January 21, 2022
Tickers ALID ATAI AWKNF CMPS
Tags Markets RVVTF GHRS
From Benzinga
Psychedelic Stock Gainers And Losers From January 20, 2022
January 20, 2022
Tickers ALID ATAI AWKNF CMPS
Tags CMPS IGXT BZI/PSYCH
From Benzinga
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
January 19, 2022
Tickers ALID ATAI AWKNF CMPS
Tags FTRP Market News ATAI
From Benzinga
Psychedelic Stock Gainers And Losers From January 18, 2022
January 18, 2022
Tickers ALID ATAI AWKNF CMPS
Tags Benzinga DMTTF MSSTF
From Benzinga
Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS
January 18, 2022
Tickers ATAI AWKNF CYBN FTRP
Tags psychedelics AWKNF Topics
From Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap